Clinical Trials in Hangzhou, China
Locations / Hangzhou, China
Delta Trials hosts 25 clinical trials conducted in Hangzhou, China, making it a notable site of clinical research activity. These trials covering 36 medical conditions and multiple therapeutic areas, reflecting the scope and diversity of clinical research in this location. The trial counts on this page reflect the most recent data ingested from ClinicalTrials.gov, tracking research history across multiple versions for Hangzhou.
25
Total Trials
36
Conditions
0
Terminated since 2020
Browse by condition (36 total)
- Acute myeloid leukemia 2 trialsAll Acute myeloid leukemia trials
- Non-small cell lung cancer 2 trialsAll Non-small cell lung cancer trials
- All Non-small cell lung cancer (nsclc) trials
- Advanced breast cancer 1 trialAll Advanced breast cancer trials
- All Prostatic neoplasms, castration-resistant trials
- All Glucosylceramide beta-glucosidase deficiency disease trials
- All Multiple myeloma and other plasma cell neoplasms trials
- Carotid artery stenting 1 trialAll Carotid artery stenting trials
- All Advanced non-small cell lung cancer trials
- Advanced malignancies 1 trialAll Advanced malignancies trials
- Early breast cancer 1 trialAll Early breast cancer trials
- Her2 mutation 1 trialAll Her2 mutation trials
- All Primary prevention of atherosclerotic cardiovascular disease trials
- Advance solid tumors 1 trialAll Advance solid tumors trials
- All Glucocerebrosidase deficiency disease trials
- Egfr mutation 1 trialAll Egfr mutation trials
- Advanced malignant tumours 1 trialAll Advanced malignant tumours trials
- Acute lymphoblastic leukemia 1 trialAll Acute lymphoblastic leukemia trials
- Juvenile psoriatic arthritis 1 trialAll Juvenile psoriatic arthritis trials
- Cerebroside lipidosis syndrome 1 trialAll Cerebroside lipidosis syndrome trials